Suchergebnisse - "Tesmoingt, Chloé"

PubPharm (10)

1

Carbon Footprint of Elective Endovascular Abdominal Aortic Aneurysm Repair

enthalten in: European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery | 2023

von Sénémaud, J. | Gouel-Chéron, A. | Tesmoingt, C. | +3

CommentOn: Lancet Planet Health. 2021 Feb;5(2):e84-e92. - PMID 33581070

2

Real-life temocillin use in Greater Paris area, effectiveness and risk factors for failure in infections caused by ESBL-producing Enterobacterales : a multicentre retrospective study

enthalten in: JAC-antimicrobial resistance | 2023

von Dinh, A. | Duran, C. | Singh, S. | +35

ErratumIn: JAC Antimicrob Resist. 2023 Jan 12;5(1):dlad002. - PMID 36644413

3

Glucocorticoids with low-dose anti-IL1 anakinra rescue in severe non-ICU COVID-19 infection : A cohort study

enthalten in: PloS one | 2020

von Borie, R. | Savale, L. | Dossier, A. | +32

4

Medication reconciliation : a prospective study in an internal medicine unit

enthalten in: Drugs & aging | 2014

von Andreoli, L. | Alexandra, J. | Tesmoingt, C. | +5

5

Medication Reconciliation: A Prospective Study in an Internal Medicine Unit

enthalten in: Drugs & aging | 2014

von Andreoli, L. | Alexandra, J. | Tesmoingt, C. | +5

6

Medication Reconciliation: A Prospective Study in an Internal Medicine Unit

enthalten in: Drugs & aging | 2014

von Andreoli, L. | Alexandra, J. | Tesmoingt, C. | +5

7

Enzyme therapy in Fabry disease : severe adverse events associated with anti-agalsidase cross-reactive IgG antibodies

enthalten in: British journal of clinical pharmacology | 2009

von Tesmoingt, C. | Lidove, O. | Reberga, A. | +5

8

Enzyme therapy in Fabry disease: severe adverse events associated with anti-agalsidase cross-reactive IgG antibodies

enthalten in: British journal of clinical pharmacology | 2009

von Tesmoingt, C. | Lidove, O. | Reberga, A. | +5

9

Gemcitabine plus oxaliplatin (GEMOX) combined with cetuximab in patients with progressive advanced stage hepatocellular carcinoma : results of a multicenter phase 2 study

enthalten in: Cancer | 2008

von Asnacios, A. | Fartoux, L. | Romano, O. | +8

10

Gemcitabine plus oxaliplatin (GEMOX) combined with cetuximab in patients with progressive advanced stage hepatocellular carcinoma

enthalten in: Cancer | 2008

von Asnacios, A. | Fartoux, L. | Romano, O. | +8

1
[1]